Stay updated on ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Sign up to get notified when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.

Latest updates to the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page. This reflects a minor metadata update to the page’s version history and does not alter study content such as eligibility, locations, or outcomes.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4. This reflects a software version update at the bottom of the page and does not affect the study information.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe Study Record Dates section shows a new revision value, updated from v3.6.2 to v3.6.3, indicating an updated revision of the study record.SummaryDifference0.0%

- Check48 days agoChange DetectedA new revision entry v3.6.2 has been added, replacing the previous v3.6.0 in the page's revision history. This indicates a minor metadata update to the ClinicalTrials.gov record rather than a modification of the study data or eligibility criteria.SummaryDifference0.0%

- Check62 days agoChange DetectedThe recruitment status now clearly indicates enrollment is closed, and the page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating headings (Intervention/Treatment) and the revision note to v3.6.0 to reflect current structure and version.SummaryDifference0.5%

- Check69 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, representing a new build/release of the page. No study content or visible features were altered.SummaryDifference0.0%

Stay in the know with updates to ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.